v3.26.1
Stockholders’ Deficit (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Stock Based Compensation Expense Recognized for Officer and Director Arrangements

The following table summarizes stock-based compensation expense recognized for all officer and director arrangements for the years ended December 31, 2025 and 2024:

 

   December 31, 2025   December 31, 2024 
         
Chief Executive Officer  $-   $3,800,000 
Chief Financial Officer   479,077    2,148,681 
Board of Directors   460,913    132,025 
Director of HR and Legal Services   -    672,000 
Total  $939,990   $6,752,706 
Schedule of Non-vested Shares Related Parties

The following is a summary of the Company’s non-vested shares at December 31, 2025 and 2024.

 

       Weighted Average 
Non-Vested Shares 

Number of Shares

   Grant Date Fair Value 
Balance - December 31, 2023   695,000   $5.24 
Granted   644,640    7.60 
Vested   (1,000,000)   6.55 
Cancelled/Forfeited   -    - 
Balance - December 31, 2024  $339,640    5.03 
Granted   150,000    3.16 
Vested   (288,880)   4.77 
Cancelled/Forfeited   -    - 
Balance - December 31, 2025   200,760   $4.00 
           
Unrecognized Compensation  $507,262      
           
Weighted average period (years)   2.57      
Schedule of Stock Granted

The following is a detail of the common stock granted, which is subject to the vesting provisions noted above at December 31, 2025 and 2024, respectively.

 

   CEO   CFO   Directors   Director of Human Resources/Legal   Total 
Balance - December 31, 2023   -    600,000    95,000    -    695,000 
Granted   500,000    -    44,640    100,000    644,640 
Vested   (500,000)   (400,000)   -    (100,000)   (1,000,000)
Cancelled/Forfeited   -    -    -    -    - 
Balance - December 31, 2024   -    200,000    139,640    -    339,640 
Granted   -    -    150,000    -    150,000 
Vested   -    (200,000)   (88,880)*   -    (288,880)
Cancelled/Forfeited   -    -    -    -    - 
Balance - December 31, 2025   -    -    200,760    -    200,760 
                          
Unrecognized Compensation  $-   $-   $507,262   $-   $507,262 
                          
Weighted average period (years)   -    -    2.57    -    2.57 
Schedule of Stock Option Transactions

Stock option transactions for the years ended December 31, 2025 and 2024 are summarized as follows:

 

           Weighted        
           Average       Weighted 
       Weighted   Remaining      Average 
       Average   Contractual   Aggregate   Grant 
Stock Options 

Number of

Options

  

Exercise

Price

  

Term

(Years)

  

Intrinsic

Value

  

Date

Fair Value

 
Outstanding - December 31, 2023   121,276   $7.79    6.47   $             -      
Vested and Exercisable - December 31, 2023   116,174   $7.43    6.61   $-      
Unvested and non-exercisable - December 31, 2023   5,101   $16.00    3.16   $-      
Granted   1,054,603   $1.78             $1.52 
Exercised   -   $-                
Cancelled/Forfeited   (9,798)  $6.45                
Outstanding - December 31, 2024   1,166,081   $2.37    6.85   $-      
Vested and Exercisable - December 31, 2024   1,166,081   $2.37    6.85   $-      
Unvested and non-exercisable - December 31, 2023   -    -         -      
Granted   1,144,116   $1.75             $1.49 
Exercised   -   $-                
Cancelled/Forfeited   (17,253)  $1.78                
Outstanding - December 31, 2025   2,292,944   $2.06    6.43   $-      
Vested and Exercisable - December 31, 2025   2,292,944   $2.06    6.43   $-      
Unvested and non-exercisable - December 31, 2023   -    -         -      
Schedule of Fair Value of Stock Options

The fair value of these stock options was determined using the Black-Scholes option pricing model with the following inputs:

 

Expected term   7 years 
Expected volatility   103%
Expected dividends   0%
Risk free interest rate   3.88%
 

The fair value of these stock options was determined using a Black-Scholes option pricing model with the following inputs:

 

Expected term   7 years 
Expected volatility   104%
Expected dividends   0%
Risk free interest rate   4.48%
 
Schedule of Stock Based Compensation Expense

Stock-based compensation expense related to stock options for the years ended December 31, 2025 and 2024 was as follows:

 

Years Ended December 31, 
2025   2024 
$1,701,735   $1,609,193 
Schedule of Warrants Activity

Warrant activity for the years ended December 31, 2025 and 2024 are summarized as follows:

 

           Weighted     
           Average     
       Weighted   Remaining   Aggregate 
   Number of   Average   Contractual   Intrinsic 
Warrants  Warrants   Exercise Price   Term (Years)   Value 
Outstanding - December 31, 2023   5,574,253   $4.81    0.86   $9,348,348 
Vested and Exercisable - December 31, 2023   5,574,253   $4.81    0.86   $9,348,348 
Unvested - December 31, 2023   -   $-    -   $- 
Granted   -   $-           
Exercised   (1,953,308)  $4.73           
Cancelled/Forfeited   (3,524,945)  $4.86           
Outstanding - December 31, 2024   96,000   $4.73    0.37   $- 
Vested and Exercisable - December 31, 2024   96,000   $4.73    0.37   $- 
Unvested and non-exercisable - December 31, 2024   -   $-    -   $- 
Granted   730,000   $5.86           
Exercised   -   $-           
Cancelled/Forfeited   (96,000)  $4.73           
Outstanding - December 31, 2025   730,000   $5.86    4.30   $- 
Vested and Exercisable - December 31, 2025   730,000   $5.86    4.30   $- 
Unvested and non-exercisable - December 31, 2025   -   $-    -   $-